Company news
Syndax Pharmaceuticals, Inc. news in 2020
Syndax Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.
Syndax Pharmaceuticals To Be Added to the NASDAQ Biotechnology Index
December 17, 2020
Syndax Announces Pricing of Public Offering of Common Stock
December 8, 2020
Syndax Pharmaceuticals Announces Additional Positive Data from Phase 1 Trial of Axatilimab in Patients with cGVHD
December 5, 2020
Syndax Pharmaceuticals to Host Axatilimab Conference Call and Webcast Featuring Two cGVHD Experts
November 29, 2020
Syndax Announces Presentation at Stifel 2020 Virtual Healthcare Conference
November 10, 2020
Syndax Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Business Update
November 1, 2020
Syndax to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 2, 2020
October 25, 2020
Syndax Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Business Update
August 5, 2020
Syndax Announces Participation in BTIG Virtual Biotechnology Conference
August 2, 2020
Syndax to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 6, 2020
July 29, 2020
Syndax Pharmaceuticals Appoints Daphne Karydas as Chief Financial Officer
July 6, 2020
Syndax Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Business Update
May 6, 2020
Syndax to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 7, 2020
April 29, 2020
Syndax Pharmaceuticals Announces Preclinical Profile and Initial Phase 1 Data Demonstrating Clinical Activity of Menin Inhibitor SNDX-5613 in Adults with Relapsed/Refractory Acute Leukemias
April 26, 2020
Syndax Pharmaceuticals Announces Three Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting
April 13, 2020
Syndax Pharmaceuticals Reports Fourth Quarter 2019 Financial Results and Provides Clinical and Business Update
March 2, 2020
Syndax Announces $35.0 Million Offering of Common Stock and Enters Term Sheet for Loan with Hercules Capital for up to $30 Million
January 30, 2020
Syndax Pharmaceuticals Highlights 2020 Clinical and Corporate Outlook
January 9, 2020
Decks in 2020
- AACR 2020
Conference · 19 slides · May 2020